Trial reportBMC health services research2025
Acceptability of home-based HPV self-sampling for cervical cancer screening among users and providers in the West region of Cameroon: a cross-sectional study.
Trial report in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06166420 (Offering Home-based Versus Hospital-based HPV Counseling and Testing for Cervical Cancer Screening in Rural West Region of Cameroon), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Offering Home-based Versus Hospital-based HPV Counseling and Testing for Cervical Cancer Screening in Rural West Region of Cameroon: a Randomised Cluster Trial
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe World Health Organization's 90-70-90 goal aims to eliminate cervical cancer (CC) as a public health issue, with a target of up to 70% of women screened by 2030. However, many countries, including Cameroon, are far from achieving this goal. Home-based human papillomavirus (HPV) self-sampling is a promising approach to improve participation rates. The main objective of this study was to explore the acceptability and feasibility of home-based HPV self-sampling in the West region of Cameroon.
methodsA quantitative, descriptive, cross-sectional study conducted between January 11 and February 05, 2024, was embedded in a cluster-randomised controlled trial comparing home- vs. hospital-based CC screening. Women eligible for CC screening, male partners or close relatives, community leaders, and healthcare professionals (HCPs) living in Dschang health district responded to a structured questionnaire. Simple and multivariate analyses were performed to assess the association between acceptability of home-based HPV self-sampling, CC screening practices, and sociodemographic factors such as education, professional status, residence, and income. Preferences for implementation (e.g., seasonal timing) were also explored.
resultsA total of 556 participants (300 women, 70 male partners, 153 HCPs, and 33 community leaders) were recruited. Overall, 77.5% of participants expressed favourable attitudes toward home-based HPV self-sampling, with acceptability rates of 73.7% for women, 65.7% for men, 90% for community leaders, and 87.6% for HCPs. Previous CC screening was reported by 33% of women, and was significantly associated with being over 40 years old (aOR = 2.1, p = 0.007), with a monthly income of > 50,000 XAF (aOR = 2.2, p = 0.049), and having good knowledge of CC (aOR = 2.6, p = 0.001). Morning screening implementation was preferred by most participants, with 60% favouring year-round screening. More than 70% preferred face-to-face communication of HPV test results from SMS or phone calls, at hospitals for women (63%), men (50%), and HCPs (65.4%); while community leaders preferred home disclosure.
conclusionHome-based HPV self-sampling was highly accepted across all study groups and was unaffected by sociodemographic factors. Previous screening practices were associated with age, income, and knowledge. Home-based HPV self-sampling screening can address access disparities to CC screening. Community involvement in planning and implementing these programs is essential to ensure their success.
trial registrationEthical Cantonal Board of Geneva, Switzerland (CCER, N°202100085), (ClinicalTrials.govID NCT06166420 / 20231204) and the National Ethics Committee for Human Health Research in Cameroon (N°2023/09/1579/CE/CNERSH/SP).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.